BIOHIT secures European distribution rights for Biomedal’s gluten immunogenic peptide tests

BIOHIT is excited to announce an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests.

FTC says PBMs ‘exercise vast control’ over healthcare, but stops short of calling for antitrust action

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 10, 2024

Slynd birth control drugmaker Exeltis hit with FDA letter over misleading social media promotion

A sponsored social media post for Slynd birth control is the latest ad offender in the eyes of the FDA’s promotions watchdog. The Office of

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

BIOHIT secures European distribution rights for Biomedal’s gluten immunogenic peptide tests

FTC says PBMs ‘exercise vast control’ over healthcare, but stops short of calling for antitrust action

Slynd birth control drugmaker Exeltis hit with FDA letter over misleading social media promotion

Putting away phones during meals cuts junk food intake among teens

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe